Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Firefly Neuroscience (AIFF) Notes Payables (2020 - 2023)

Historic Notes Payables for Firefly Neuroscience (AIFF) over the last 3 years, with Q3 2023 value amounting to $94071.0.

  • Firefly Neuroscience's Notes Payables changed N/A to $94071.0 in Q3 2023 from the same period last year, while for Sep 2023 it was $94071.0, marking a year-over-year change of. This contributed to the annual value of $450000.0 for FY2020, which is N/A changed from last year.
  • Per Firefly Neuroscience's latest filing, its Notes Payables stood at $94071.0 for Q3 2023.
  • Firefly Neuroscience's Notes Payables' 5-year high stood at $1.5 million during Q2 2021, with a 5-year trough of $37157.0 in Q3 2020.
  • Moreover, its 3-year median value for Notes Payables was $186115.0 (2023), whereas its average is $450704.1.
  • Data for Firefly Neuroscience's Notes Payables shows a peak YoY increase of 312456.33% (in 2021) and a maximum YoY decrease of 91788.37% (in 2021) over the last 5 years.
  • Firefly Neuroscience's Notes Payables (Quarter) stood at $450000.0 in 2020, then surged by 166.26% to $1.2 million in 2021, then tumbled by 92.15% to $94071.0 in 2023.
  • Its Notes Payables stands at $94071.0 for Q3 2023, versus $186115.0 for Q2 2023 and $276173.0 for Q1 2023.